Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC-Reference-Cited by-同舟云学术

Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC

Published:2017-12-12 Issue:1 Volume:21 Page:169-177
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Zhao Xiaoliang¹²³,Wen Xiaohua⁴,Wei Wei¹²³,Su Yanjun¹²³,You Jian¹²³,Gong Liqun¹²³,Zhang Zhenfa¹²³,Wang Meng¹²³,Xiao Jianyu²³⁵,Wei Xiyin³⁶,Wang Changli¹²³

Affiliation:

1. Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China

2. Tianjin Lung Cancer Center, Tianjin 300060, China

3. Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China

4. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China

5. Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China

6. Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference32 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Pathology of lung cancer;Travis;Clin Chest Med,2011

3. Long-term prognosis after surgery for pathological stage III lung cancer;Togashi;Kyobu Geka,2005

4. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth;O’Reilly;Cell,1997

5. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma;Dhanabal;Cancer Res,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future of anti-angiogenic drugs in lung cancer;Clinical and Experimental Medicine;2023-03-15

2. Endostar regulates EMT, migration and invasion of lung cancer cells through the HGF-Met pathway;Molecular and Cellular Probes;2019-06